ReShape Lifesciences Balance Sheet Health
Financial Health criteria checks 4/6
ReShape Lifesciences has a total shareholder equity of $4.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $8.2M and $3.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$2.38m |
Equity | US$4.53m |
Total liabilities | US$3.70m |
Total assets | US$8.23m |
Recent financial health updates
Recent updates
It's A Story Of Risk Vs Reward With ReShape Lifesciences Inc. (NASDAQ:RSLS)
Apr 18ReShape wins FDA clearance for device used in weight loss surgery
Aug 10Analysts Have Lowered Expectations For ReShape Lifesciences Inc. (NASDAQ:RSLS) After Its Latest Results
Mar 31Health Check: How Prudently Does ReShape Lifesciences (NASDAQ:RSLS) Use Debt?
Dec 09Does ReShape Lifesciences (NASDAQ:RSLS) Have A Healthy Balance Sheet?
Aug 24Financial Position Analysis
Short Term Liabilities: RSLS's short term assets ($7.9M) exceed its short term liabilities ($3.5M).
Long Term Liabilities: RSLS's short term assets ($7.9M) exceed its long term liabilities ($178.0K).
Debt to Equity History and Analysis
Debt Level: RSLS is debt free.
Reducing Debt: RSLS has no debt compared to 5 years ago when its debt to equity ratio was 5.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RSLS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: RSLS has less than a year of cash runway if free cash flow continues to grow at historical rates of 6.9% each year.